| http://www.w3.org/ns/prov#value | - Our goal is to become a recognizable name in the human diagnostics space and we feel that the timing of these branding changes is auspicious, as we draw closer to commercializing APPY1 in Europe and initiating a pivotal clinical study for purposes of gaining regulatory clearance in the United States.Venaxis is revising and updating the Company web site and corporate materials, including the logo,
|
